Patents by Inventor Fritz Schomburg

Fritz Schomburg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250109173
    Abstract: Provided is a recombinant polypeptide containing at least one immunogenic fragment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) spike glycoprotein, and pharmaceutical compositions containing the same.
    Type: Application
    Filed: December 30, 2022
    Publication date: April 3, 2025
    Applicant: BOOST BIOPHARMA, INC.
    Inventors: Fritz Schomburg, David Rancour
  • Publication number: 20250090654
    Abstract: Provided is a recombinant polypeptide containing at least one immunogenic fragment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spike glycoprotein. Also provided are a method for preventing, inhibiting, reducing, eliminating, protecting, or delaying the onset of an infection or an infectious clinical condition caused by a coronavirus in a subject which includes administering to the subject the recombinant polypeptide, and a method for inducing an immune response against a coronavirus in a subject, which includes administering to the subject the recombinant polypeptide.
    Type: Application
    Filed: December 30, 2022
    Publication date: March 20, 2025
    Applicant: BOOST BIOPHARMA, INC.
    Inventors: Fritz Schomburg, David Rancour
  • Publication number: 20130110149
    Abstract: The present invention provides synthetic gemstones for use in contact with human tissue, compositions, devices and systems comprising such gemstones, and methods of use thereof.
    Type: Application
    Filed: October 26, 2012
    Publication date: May 2, 2013
    Inventor: Fritz Schomburg
  • Publication number: 20050251883
    Abstract: The present invention discloses the function, the cDNA sequences, and the expressed amino acid sequences of two genes the expression of which reduced bioactive GA levels and the height of a plant. This information enables creation of dwarf transgenic plants or transgenic plants with a specific dwarf organ.
    Type: Application
    Filed: June 15, 2005
    Publication date: November 10, 2005
    Inventors: Richard Amasino, Fritz Schomburg, Scott Michaels, Colleen Bizzell
  • Publication number: 20050091717
    Abstract: The present invention provides genetic identification and use information about a family of genes, the FLOWERING LOCUS C (FLC) genes, that is part of the regulate the timing of the onset of flowering in plants. This information enables creation of transgenic plants in which the timing of the flowering of the plants has been selectively altered. Since these genes natively act to delay the time of flowering in plants, enhancing activity of the FLC protein delays the timing of flowering initiation while inhibiting the activity of FLC advances the timing of the start of flowering. A representative number of samples of the gene family are described. Members of the gene family are demonstrated to work in other plant species as well.
    Type: Application
    Filed: June 20, 2003
    Publication date: April 28, 2005
    Inventors: Richard Amasino, Fritz Schomburg, Scott Michaels, Si-Bum Sung, Katia Scortecci